Cargando…
Gut Microbiota Imbalance in Metastatic Colorectal Patients Treated With EGFRI and Long-Term Antibiotic Therapy for Cutaneous Toxicity: A Pilot Study
Patients with metastatic colorectal cancer (mCRC) frequently experience epidermal growth factor inhibitors (EGFRI)-induced skin side effects. Antibiotic treatment with doxycycline is often required in order to manage the skin and mucosal toxicity. Since these patients already have significant gut dy...
Autores principales: | Popa, Cristina-Maria, Ianosi, Simona-Laura, Dorobantu, Stefania-Cornelia, Saftoiu, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194878/ https://www.ncbi.nlm.nih.gov/pubmed/35712333 http://dx.doi.org/10.7759/cureus.25007 |
Ejemplares similares
-
Cutaneous Toxicity in Oncologic Patients Receiving Epidermal Growth Factor Receptor Inhibitors
por: POPA, CRISTINA-MARIA, et al.
Publicado: (2021) -
Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial
por: Vincenzi, Bruno, et al.
Publicado: (2020) -
Xerosis and pruritus as major EGFRI-associated adverse events
por: Clabbers, Julia M. K., et al.
Publicado: (2015) -
Metastatic Cutaneous Angiosarcoma: A Rare Entity
por: Blanco Jimenez, Javier, et al.
Publicado: (2021) -
Cutaneous Metastatic Breast Cancer Masked by Hidradenitis Suppurativa
por: Cohen-Kurzrock, Rena A, et al.
Publicado: (2021)